ShadowBuys

Lobbying disclosures · Lobbying report

UNH: third_quarter 2026 lobbying report

Monitored general issues and proposals concerning Medicare and Medicaid. Monitored developments on the No UPCODE Act. Monitored general issues on the No Surprise Act.

Follow UNH
Became public
Oct 20, 2026, 6:37 PM EDT
Event / period date
Not stated
Collected
Nov 8, 2026, 10:00 PM EST

Why this is connected

Exact legal-name match: UNITEDHEALTH GROUP INC (https://www.sec.gov/Archives/edgar/data/731766/).

Reported lobbying amounts

Income: $90,000.00

These are different reporting measures. They are not added together or treated as spending on one particular bill.

Source evidence

Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/9c552095-aaeb-41d6-8eb0-75365aa923db/","filing_uuid":"9c552095-aaeb-41d6-8eb0-75365aa923db","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/9c552095-aaeb-41d6-8eb0-75365aa923db/print/","filing_document_content_type":"text/html","income":"90000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Paul Miller","dt_posted":"2026-10-20T18:37:07-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1730 Pennsylvania Avenue NW","registrant_address_2":"Suite 500","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":401103834,"url":"https://lda.gov/api/v1/registrants/401103834/","house_registrant_id":null,"name":"THEGROUP DC, LLC","description":"​Consulting and lobbying services.","address_1":"1730 Pennsylvania Avenue NW","address_2":"Suite 500","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"PAUL L. MILLER III","contact_telephone":"+1 202-386-7282","dt_updated":"2026-07-20T16:34:02.921317-04:00"},"client":{"id":212016,"url":"https://lda.gov/api/v1/clients/212016/","client_id":431,"name":"UNITEDHEALTH GROUP, INC.","general_description":"Healthcare company","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2021-09-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Monitored general issues and proposals concerning Medicare and Medicaid. Monitored developments on the No UPCODE Act. Monitored general issues on the No Surprise Act.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":64027,"prefix":null,"prefix_display":null,"first_name":"SUDAFI","nickname":null,"middle_name":null,"last_name":"HENRY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139636,"prefix":"mr","prefix_display":"MR.","first_name":"JORGE","nickname":null,"middle_name":"A","last_name":"AGUILAR","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148423,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"CLEARY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}

Congressional trading in UNH

These disclosures provide context. Their presence does not establish a link between a trader and the event.

Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.